List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 72 studies with search of: Acromegaly
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Glucose Tolerance in Acromegaly: The Influence of GH-excess on Glucose Metabolism and Insulin Resistance
Conditions: Acromegaly;   Diabetes;   Insulin Resistance;   Impaired Glucose Tolerance
Intervention:
2 Recruiting Lanreotide Levels in Acromegaly
Condition: Acromegaly
Intervention: Other: Blood draw
3 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
4 Active, not recruiting Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Conditions: Carcinoid Tumor;   Acromegaly
Intervention: Drug: Pasireotide
5 Not yet recruiting Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Somatuline Autogel
6 Recruiting Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Intervention: Drug: Sandostatin LAR
7 Active, not recruiting Surgical Versus Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention:
8 Completed Fractionated Stereotactic Radiotherapy in Patients With Acromegaly
Condition: Acromegaly
Intervention: Radiation: fractionated stereotactic radiotherapy
9 Completed Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
10 Active, not recruiting An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide
11 Completed Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide LAR - pituitary surgery
12 Completed Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide-LAR or lanreotide;   Procedure: Transsphenoidal adenomectomy
13 Recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Interventions: Drug: Pasireotide;   Drug: Octreotide
14 Completed Acute Application of Pegvisomant and Octreotide in Acromegaly
Condition: Acromegaly
Interventions: Drug: pegvisomant;   Drug: combination with somatostatin analogue octreotide;   Drug: combination with dopamine agonist cabergoline
15 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
16 Completed Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Condition: Acromegaly
Interventions: Drug: Somatuline Autogel (lanreotide acetate);   Behavioral: Home administration
17 Completed Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
18 Recruiting Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
19 Recruiting A Study Examining the Peri- and Post-Operative Dynamics of the Growth Hormone (GH) - IGF-1 Axis in Subjects With Acromegaly During the First Year After Surgical Resection
Condition: Acromegaly
Intervention: Other: OGTT
20 Recruiting Physiopathology of Sodium Retention in Acromegaly
Condition: Acromegaly
Intervention: Drug: furosemide

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services